 Thu Doan
Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens | 3 | 2025 | 362 | 1.000 |
Why?
| | Vaccines | 2 | 2022 | 406 | 0.640 |
Why?
| | Lymph Nodes | 2 | 2025 | 502 | 0.330 |
Why?
| | Receptors, Pattern Recognition | 1 | 2022 | 14 | 0.190 |
Why?
| | Vaccinia virus | 1 | 2022 | 43 | 0.190 |
Why?
| | Mycophenolic Acid | 1 | 2023 | 118 | 0.190 |
Why?
| | Endothelial Cells | 2 | 2025 | 816 | 0.190 |
Why?
| | Single-Cell Analysis | 2 | 2025 | 338 | 0.190 |
Why?
| | Measles | 1 | 2022 | 46 | 0.180 |
Why?
| | Methotrexate | 1 | 2023 | 255 | 0.180 |
Why?
| | Uveitis | 1 | 2023 | 148 | 0.180 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 76 | 0.170 |
Why?
| | Immune System | 1 | 2022 | 183 | 0.170 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2022 | 130 | 0.170 |
Why?
| | Encephalitis | 1 | 2022 | 137 | 0.160 |
Why?
| | Intraocular Lymphoma | 1 | 2019 | 3 | 0.160 |
Why?
| | Ganciclovir | 1 | 2019 | 53 | 0.160 |
Why?
| | Eye Neoplasms | 1 | 2019 | 28 | 0.160 |
Why?
| | Uveitis, Anterior | 1 | 2019 | 24 | 0.160 |
Why?
| | Retinal Neoplasms | 1 | 2019 | 36 | 0.150 |
Why?
| | Diphosphonates | 1 | 2019 | 69 | 0.150 |
Why?
| | Vitreous Body | 1 | 2019 | 122 | 0.150 |
Why?
| | Bone Density Conservation Agents | 1 | 2019 | 83 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2023 | 2064 | 0.140 |
Why?
| | Osteoporotic Fractures | 1 | 2019 | 61 | 0.140 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 197 | 0.140 |
Why?
| | Immunosuppressive Agents | 1 | 2023 | 854 | 0.140 |
Why?
| | Respiratory Tract Infections | 1 | 2022 | 385 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2019 | 501 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2019 | 747 | 0.100 |
Why?
| | Dendritic Cells | 2 | 2025 | 505 | 0.080 |
Why?
| | Transcriptome | 2 | 2025 | 1003 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2023 | 1983 | 0.060 |
Why?
| | Humans | 8 | 2025 | 141197 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2025 | 5887 | 0.050 |
Why?
| | Measles virus | 1 | 2022 | 20 | 0.050 |
Why?
| | Phosphorothioate Oligonucleotides | 1 | 2021 | 11 | 0.040 |
Why?
| | Caveolae | 1 | 2021 | 18 | 0.040 |
Why?
| | Ovalbumin | 1 | 2021 | 196 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2021 | 330 | 0.040 |
Why?
| | Genome, Viral | 1 | 2022 | 223 | 0.040 |
Why?
| | Thailand | 1 | 2019 | 17 | 0.040 |
Why?
| | Endocytosis | 1 | 2021 | 175 | 0.040 |
Why?
| | Taiwan | 1 | 2019 | 46 | 0.040 |
Why?
| | Visual Acuity | 1 | 2023 | 443 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 220 | 0.040 |
Why?
| | Administration, Topical | 1 | 2019 | 150 | 0.040 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2019 | 105 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2019 | 105 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 533 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 450 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2019 | 338 | 0.040 |
Why?
| | Eye Diseases | 1 | 2019 | 92 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1764 | 0.040 |
Why?
| | Viral Load | 1 | 2019 | 506 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 803 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2021 | 698 | 0.030 |
Why?
| | Mice | 2 | 2025 | 18055 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2181 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1444 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1556 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2023 | 5200 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1654 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 4208 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1560 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2021 | 2828 | 0.020 |
Why?
| | Animals | 2 | 2025 | 37663 | 0.020 |
Why?
| | Female | 3 | 2025 | 75522 | 0.020 |
Why?
| | Time Factors | 1 | 2021 | 6956 | 0.020 |
Why?
| | Brain | 1 | 2022 | 2858 | 0.020 |
Why?
| | Middle Aged | 2 | 2023 | 34438 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 11120 | 0.020 |
Why?
| | Adult | 2 | 2023 | 39181 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7856 | 0.020 |
Why?
| | Male | 2 | 2023 | 69789 | 0.010 |
Why?
| | United States | 1 | 2019 | 15220 | 0.010 |
Why?
| | Child | 1 | 2022 | 22310 | 0.010 |
Why?
| | Aged | 1 | 2019 | 24576 | 0.010 |
Why?
|
|
Doan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|